Shelly Fan in Singularity Hub:
Breakthroughs in medicine are exciting. They promise to alleviate human suffering, sometimes on global scales. But it takes years, even decades, for new drugs and therapies to go from research to your medicine cabinet. Along the way, most will stumble at some point. Clinical trials, which test therapies for safety and efficacy, are the final hurdle before approval. Last year was packed with clinical trials news. Blockbuster medications Ozempic and Wegovy still dominated headlines. Although known for their impact on weight loss, that’s not all they can do. In an analysis of over 1.6 million patients, the drugs seemed to block 10 obesity-associated cancers—including those of the liver, kidney, pancreas, and skin cancers. Another trial over one year found that a similar type of drug slowed cognitive decline in people with mild Alzheimer’s disease.
So, what’s poised to take the leap from breakthrough to clinical approval in 2025? Here’s what to expect in the year ahead.
More here.
Enjoying the content on 3QD? Help keep us going by donating now.